141 related articles for article (PubMed ID: 31615087)
21. Co-grinding with surfactants as a new approach to enhance in vitro dissolution of praziquantel.
Gaggero A; Jurišić Dukovski B; Radić I; Šagud I; Škorić I; Cinčić D; Jug M
J Pharm Biomed Anal; 2020 Sep; 189():113494. PubMed ID: 32745904
[TBL] [Abstract][Full Text] [Related]
22. Improving the Dissolution of Triclabendazole from Stable Crystalline Solid Dispersions Formulated for Oral Delivery.
Real D; Orzan L; Leonardi D; Salomon CJ
AAPS PharmSciTech; 2019 Dec; 21(1):16. PubMed ID: 31807963
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000.
Vijaya Kumar SG; Mishra DN
Yakugaku Zasshi; 2006 Aug; 126(8):657-64. PubMed ID: 16880724
[TBL] [Abstract][Full Text] [Related]
24. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
25. Solubility, dissolution rate and bioavailability enhancement of irbesartan by solid dispersion technique.
Boghra RJ; Kothawade PC; Belgamwar VS; Nerkar PP; Tekade AR; Surana SJ
Chem Pharm Bull (Tokyo); 2011; 59(4):438-41. PubMed ID: 21467670
[TBL] [Abstract][Full Text] [Related]
26. Dramatic improvement in dissolution rate of albendazole by a simple, one-step, industrially scalable technique.
Ghanbarzadeh S; Khalili A; Jouyban A; Emami S; Javadzadeh Y; Solhi M; Hamishehkar H
Res Pharm Sci; 2016 Dec; 11(6):435-444. PubMed ID: 28003836
[TBL] [Abstract][Full Text] [Related]
27. Effect of PEG 4000 on the dissolution rate of naproxen.
Vélaz I; Sánchez M; Martín C; Martínez-Ohárriz MC
Eur J Drug Metab Pharmacokinet; 1998; 23(2):103-8. PubMed ID: 9725465
[TBL] [Abstract][Full Text] [Related]
28. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
Al-Hamidi H; Obeidat WM; Nokhodchi A
Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
[TBL] [Abstract][Full Text] [Related]
29. In Vitro and In Vivo Evaluation of Casein as a Drug Carrier for Enzymatically Triggered Dissolution Enhancement from Solid Dispersions.
Bani-Jaber A; Alshawabkeh I; Abdullah S; Hamdan I; Ardakani A; Habash M
AAPS PharmSciTech; 2017 Jul; 18(5):1750-1759. PubMed ID: 27752935
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
31. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
[TBL] [Abstract][Full Text] [Related]
32. Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability.
Krstić M; Popović M; Dobričić V; Ibrić S
Molecules; 2015 Aug; 20(8):14684-98. PubMed ID: 26287134
[TBL] [Abstract][Full Text] [Related]
33. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
34. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis.
Semalty A
Expert Opin Drug Deliv; 2014 Aug; 11(8):1255-72. PubMed ID: 24909802
[TBL] [Abstract][Full Text] [Related]
35. Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction.
Adeyeye MC; Mwangi E; Katondo B; Jain A; Ichikawa H; Fukumori Y
J Microencapsul; 2005 Jun; 22(4):333-42. PubMed ID: 16214782
[TBL] [Abstract][Full Text] [Related]
36. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical characterization and dissolution study of solid dispersions of ketoconazole with nicotinamide.
Aggarwal AK; Jain S
Chem Pharm Bull (Tokyo); 2011; 59(5):629-38. PubMed ID: 21532202
[TBL] [Abstract][Full Text] [Related]
38. Solid dispersions of telaprevir with improved solubility prepared by co-milling: formulation, physicochemical characterization, and cytotoxicity evaluation.
Xiong X; Zhang M; Hou Q; Tang P; Suo Z; Zhu Y; Li H
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110012. PubMed ID: 31546459
[TBL] [Abstract][Full Text] [Related]
39. In sight into tadalafil - block copolymer binary solid dispersion: Mechanistic investigation of dissolution enhancement.
Mehanna MM; Motawaa AM; Samaha MW
Int J Pharm; 2010 Dec; 402(1-2):78-88. PubMed ID: 20933589
[TBL] [Abstract][Full Text] [Related]
40. The preparation and physicochemical characterization of eprosartan mesylate-laden polymeric ternary solid dispersions for enhanced solubility and dissolution rate of the drug.
Yousaf AM; Zulfiqar S; Shahzad Y; Hussain T; Mahmood T; Jamshaid M
Polim Med; 2018; 48(2):69-75. PubMed ID: 30916494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
